| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 18th December 2020 | Daniel F Voytas | 5,026 | Open or private sale | $4.75 | $23,873.50 |
| 2nd November 2020 | Travis Frey | 150 | Open or private purchase | $3.26 | $489.33 |
| 16th October 2020 | S.A. Cellectis | 1,250,000 | Other acquisition or disposition | $4.00 | $5,000,000.00 |
| 1st October 2020 | Travis Frey | 150 | Open or private purchase | $5.47 | $820.10 |
| 30th September 2020 | James Blome | 4,140 | Open or private sale | $5.59 | $23,123.56 |
| 10th September 2020 | Philippe Dumont | 3,000 | Open or private purchase | $5.91 | $17,728.80 |
| 1st September 2020 | Travis Frey | 150 | Open or private purchase | $5.41 | $811.01 |
| 14th August 2020 | Philippe Dumont | 2,000 | Open or private purchase | $7.49 | $14,970.40 |
| 3rd August 2020 | Travis Frey | 150 | Open or private purchase | $4.36 | $653.90 |
| 2nd July 2020 | Philippe Dumont | 236 | Open or private sale | $4.70 | $1,109.20 |
Calyxt
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 4/10.
Calyxt is a healthy food ingredient company. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010.
Ticker: CLXT
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
SEC Central Index Key (CIK): 1705843
Employees: 75
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
Restructuring Charges of $600 Th for the period Aug 2020 to Aug 2020 in the context of Subsequent event
Fundamentals
Cash at Carrying Value: $4 M (0%)
Inventory, Net: $5 M (0%)
Assets, Current: $44 M (-30%)
Property, Plant and Equipment, Net: $23 M (-2%)
Other Assets, Noncurrent: $427 Th (31%)
Assets: $68 M (-22%)
Accounts Payable, Current: $572 Th (-46%)
Accrued Liabilities, Current: $2 M (-21%)
Liabilities, Current: $5 M (-35%)
Other Liabilities, Noncurrent: $132 Th (-12%)
Liabilities: $24 M (-4%)
Common Stock, Value, Issued: $3 Th (0%)
Common Stock, Shares, Issued: $33 M (0%)
Additional Paid in Capital, Common Stock: $189 M (1%)
Retained Earnings (Accumulated Deficit): $144 M (17%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $41 Th (141%)
Stockholders' Equity (Parent): $44 M (0%)
Liabilities and Equity: $68 M (-22%)
Revenue: $2 M (-50%)
Cost of Revenue: $5 M (-42%)
Gross Margin: $3 M (-33%)
Research and Development: $3 M (-49%)
Sales and Marketing: $1 M (-53%)
General and Administrative Expenses: $4 M (-55%)
Operating Income/Loss: $11 M (-49%)
News
Calyxt To Exit Farming Operations And Focus On Seed Science
10th December 2020
Wall Street Breakfast: The Week Ahead
15th November 2020
Stocks To Watch: Spotlight On Nvidia, Walmart, JD.com And Nio
14th November 2020
DXP Enterprises Reports Third Quarter 2020 Results
6th November 2020